SAM
BMY icon

Storebrand Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

Storebrand Asset Management’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$101M Buy
1,753,508
+73,476
+4% +$4.22M 0.25% 86
2026
Q1 		$102M Buy
1,680,032
+32,657
+2% +$1.9M 0.29% 72
2025
Q4 		$88.9M Sell
1,647,375
-23,826
-1% -$1.15M 0.24% 90
2025
Q3 		$75.4M Buy
1,671,201
+29,860
+2% +$1.39M 0.2% 105
2025
Q2 		$76M Buy
1,641,341
+28,270
+2% +$1.39M 0.22% 96
2025
Q1 		$98.4M Buy
1,613,071
+48,574
+3% +$2.83M 0.32% 68
2024
Q4 		$88.5M Buy
1,564,497
+210,199
+16% +$11.7M 0.27% 76
2024
Q3 		$70.1M Sell
1,354,298
-161,961
-11% -$7.6M 0.22% 106
2024
Q2 		$63M Sell
1,516,259
-415,317
-22% -$18.6M 0.21% 107
2024
Q1 		$105M Buy
1,931,576
+144,416
+8% +$7.36M 0.36% 56
2023
Q4 		$91.7M Buy
1,787,160
+194,728
+12% +$10.2M 0.33% 70
2023
Q3 		$92.4M Buy
1,592,432
+106,928
+7% +$6.55M 0.44% 43
2023
Q2 		$95M Sell
1,485,504
-6,235
-0.4% -$418K 0.43% 42
2023
Q1 		$103M Sell
1,491,739
-18,572
-1% -$1.31M 0.52% 32
2022
Q4 		$109M Buy
1,510,311
+53,356
+4% +$4.02M 0.6% 26
2022
Q3 		$104M Sell
1,456,955
-9,635
-0.7% -$699K 0.63% 29
2022
Q2 		$113M Buy
1,466,590
+30,789
+2% +$2.34M 0.64% 27
2022
Q1 		$105M Buy
1,435,801
+105,799
+8% +$7.1M 0.49% 37
2021
Q4 		$82.9M Buy
1,330,002
+15,730
+1% +$923K 0.37% 56
2021
Q3 		$77.8M Buy
1,314,272
+8,401
+0.6% +$553K 0.38% 52
2021
Q2 		$87.3M Buy
1,305,871
+72,039
+6% +$4.7M 0.42% 47
2021
Q1 		$77.9M Buy
1,233,832
+106,258
+9% +$6.61M 0.41% 50
2020
Q4 		$69.9M Buy
1,127,574
+61,159
+6% +$3.76M 0.41% 51
2020
Q3 		$64.3M Buy
1,066,415
+31,847
+3% +$1.92M 0.46% 47
2020
Q2 		$60.8M Buy
1,034,568
+20,165
+2% +$1.21M 0.5% 42
2020
Q1 		$56.5M Buy
+1,014,403
New +$62M 0.59% 32

Other funds holding BMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Storebrand Asset Management's BMY Position: Q2 2026 in Review

Storebrand Asset Management increased its Bristol-Myers Squibb (BMY) stake by 4.4% in Q2 2026, buying an estimated $4.22M and bringing the position to 1,753,508 shares worth $101M. The position accounts for 0.25% of the portfolio, ranked #86.

Storebrand Asset Management first reported a position in BMY in Q1 2020 and has held it in 26 quarters since. The position peaked at $113M in Q2 2022. 2,401 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Storebrand Asset Management held 1,753,508 shares of Bristol-Myers Squibb worth $101M as of Q2 2026.
  • Storebrand Asset Management bought 73,476 Bristol-Myers Squibb shares in Q2 2026, an estimated $4.22M.
  • Bristol-Myers Squibb made up 0.25% of Storebrand Asset Management's portfolio in Q2 2026, its #86 holding.
  • Storebrand Asset Management first reported a position in Bristol-Myers Squibb in Q1 2020 and has held it in 26 quarters since.
  • Storebrand Asset Management's Bristol-Myers Squibb position peaked at $113M in Q2 2022.
  • 2,401 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Storebrand Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.